Literature DB >> 15971387

Risk factors for prevalence of and mortality related to restriction on spirometry: findings from the First National Health and Nutrition Examination Survey and follow-up.

D M Mannino1, F Holguin, B I Pavlin, J M Ferdinands.   

Abstract

OBJECTIVE: To define risk factors for both restriction on spirometry and subsequent mortality in a national cohort of US adults.
METHODS: Participants in the First National Health and Nutrition Examination Survey (NHANES I) were followed for up to 22 years. Subjects were classified using the forced expiratory volume in one second (FEV1), the forced vital capacity (FVC), and the FEV1/FVC ratio into subgroups with and without restriction on spirometry. Regression models were developed to determine risk factors for restriction on spirometry and death.
RESULTS: Our final cohort consisted of 4320 subjects, of whom 481 (10.3 weighted %) had restriction on spirometry. The largest risk factors for restriction on spirometry were a cardiothoracic ratio of >55% (OR 4.3, 95%CI 3.1-5.9), race other than black or white (OR 3.7, 95%CI 1.8-7.8), and a history of stroke or paralysis (OR 1.8, 95%CI 1.1-2.9). The overall mortality rate was increased in subjects with restriction on spirometry (25.7 vs. 10.3 deaths per 1000 person-years).
CONCLUSIONS: Restriction on spirometry is associated with comorbid disease and increased mortality, and is present in a significant proportion of the population.

Entities:  

Mesh:

Year:  2005        PMID: 15971387

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN: 1027-3719            Impact factor:   2.373


  35 in total

1.  Clinical and radiographic predictors of GOLD-unclassified smokers in the COPDGene study.

Authors:  Emily S Wan; John E Hokanson; James R Murphy; Elizabeth A Regan; Barry J Make; David A Lynch; James D Crapo; Edwin K Silverman
Journal:  Am J Respir Crit Care Med       Date:  2011-04-14       Impact factor: 21.405

2.  Imaging Features of Chronic Bronchitis with Preserved Ratio and Impaired Spirometry (PRISm).

Authors:  Xia Wei; Qi Ding; Nan Yu; Jiuyun Mi; Jingting Ren; Jie Li; Shudi Xu; Yanzhong Gao; Youmin Guo
Journal:  Lung       Date:  2018-09-14       Impact factor: 2.584

3.  Cigarette smoking is associated with subclinical parenchymal lung disease: the Multi-Ethnic Study of Atherosclerosis (MESA)-lung study.

Authors:  David J Lederer; Paul L Enright; Steven M Kawut; Eric A Hoffman; Gary Hunninghake; Edwin J R van Beek; John H M Austin; Rui Jiang; Gina S Lovasi; R Graham Barr
Journal:  Am J Respir Crit Care Med       Date:  2009-06-19       Impact factor: 21.405

Review 4.  Subclinical interstitial lung disease: why you should care.

Authors:  Tracy J Doyle; Gary M Hunninghake; Ivan O Rosas
Journal:  Am J Respir Crit Care Med       Date:  2012-02-23       Impact factor: 21.405

5.  Respiratory impairment and COPD hospitalisation in older persons: a competing risk analysis.

Authors:  Carlos A Vaz Fragoso; John Concato; Gail McAvay; Peter H Van Ness; Thomas M Gill
Journal:  Eur Respir J       Date:  2012-01-20       Impact factor: 16.671

6.  Morbidity and mortality associated with the restrictive spirometric pattern: a longitudinal study.

Authors:  Stefano Guerra; Duane L Sherrill; Claire Venker; Christina M Ceccato; Marilyn Halonen; Fernando D Martinez
Journal:  Thorax       Date:  2010-06       Impact factor: 9.139

7.  Preserved Ratio Impaired Spirometry in a Spirometry Database.

Authors:  Andrei Schwartz; Nicholas Arnold; Becky Skinner; Jacob Simmering; Michael Eberlein; Alejandro P Comellas; Spyridon Fortis
Journal:  Respir Care       Date:  2020-09-01       Impact factor: 2.258

8.  Factors associated with abnormal spirometry among HIV-infected individuals.

Authors:  M Bradley Drummond; Laurence Huang; Philip T Diaz; Gregory D Kirk; Eric C Kleerup; Alison Morris; William Rom; Michael D Weiden; Enxu Zhao; Bruce Thompson; Kristina Crothers
Journal:  AIDS       Date:  2015-08-24       Impact factor: 4.177

9.  The prognostic significance of lung function in stable heart failure outpatients.

Authors:  Louis Lind Plesner; Morten Dalsgaard; Morten Schou; Lars Køber; Jørgen Vestbo; Erik Kjøller; Kasper Iversen
Journal:  Clin Cardiol       Date:  2017-09-13       Impact factor: 2.882

10.  Lung function decline and outcomes in an elderly population.

Authors:  D M Mannino; K J Davis
Journal:  Thorax       Date:  2006-03-03       Impact factor: 9.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.